Mimicking Biotech: Pharmas Move to Innovative R&D Models
This article was originally published in RPM Report
Executive Summary
Large pharmaceutical developers have relied too long on the traditional fully integrated pharma company model. There are innovative new business models which Big Pharma should be ready to embrace.